Skip to content

A Study on the Application of a Weight Management Program for Patients in the Convalescence Phase of Acute Pancreatitis

Preliminary Application of a Weight Management Program Based on the Theory of Planned Behavior in Patients with Acute Pancreatitis During the Convalescence Phase

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126056
Enrollment
Unknown
Registered
2026-06-03
Start date
2026-06-03
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Interventions

Intervention Group:Theory of Planned Behavior-Based Weight Management Program

Sponsors

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for acute pancreatitis (AP) in the "2012 Revised Atlanta Classification" (at least two of the following: a. typical abdominal pain; b. serum amylase and/or lipase >= 3 times the upper limit of normal; c. imaging findings consistent with AP), and has completed acute-phase treatment and been discharged (note: mild, moderately severe, and severe cases are all included, without restriction based on severity); 2. Age >= 18 years; 3. Discharged within 12 months (inclusive); 4. Conscious, with normal communication and comprehension abilities, able to independently complete questionnaires; 5. Voluntarily participates in this study and has signed a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Presence of severe cognitive dysfunction or mental disorders, making it impossible to cooperate with the study; 2. Women who are pregnant or breastfeeding; 3. Other conditions that the researcher believes may affect the study results or increase the risk to participants (such as severe arrhythmia, uncontrolled hypertension, myocardial infarction within the past 3 months, etc.); 4. Concurrent severe organ failure (such as heart, liver, or kidney failure) or terminal malignant tumor; 5. Iatrogenic acute pancreatitis, idiopathic pancreatitis; 6. Acute exacerbation of chronic pancreatitis; 7. Long-term use of medications that may significantly affect body weight (such as glucocorticoids, insulin weight-loss drugs, etc.) with unstable dosages; 8. Participation in other clinical studies that may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
Intervention Completion Rate;Recruitment Rate;Waist Circumference;Participant Satisfaction;Weight Management Behavior Score;

Secondary

MeasureTime frame
Triglycerides;Body Fat Percentage;Recurrence;Adverse Event Rate;Fasting Blood Glucose;TPB Core Constructs Score;Body Mass Index (BMI);Body Weight;

Countries

China

Contacts

Public ContactDing WeiYan

The FIrst Affiliated Hospital, College of Medicine, Zhejiang University

dd925@163.com+86 571 8723 3221

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026